IP Library Granted Patent US 10,794,898
Granted Patent B2
US 10,794,898 · App. 14/598,707 · Granted Oct 6, 2020

High-throughput, high-precision methods for detecting protein structural changes in living cells

Inventors: David D. Thomas (Minneapolis, MN); Simon Joseph Gruber (Brooklyn, NY); Razvan L. Cornea (Saint Paul, MN); Gregory David Gillispie (Falcon Heights, MN); Kurt C. Peterson (Saint Paul, MN); Seth Louis Robia (Westchester, IL)
Assignees: Regents of the University of Minnesota; Loyola University Chicago
G01N33/502G01N21/6408G01N21/6428G01N33/582G01N2021/6441
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,794,898
App. No.
14/598,707
Granted
Oct 6, 2020
Kind
B2
Abstract

Methods for identifying a compound that alters fluorescence resonance energy transfer (FRET) of a protein. The methods include use of a genetically engineered cell that includes a target protein. The target protein includes one or more heterologous domains. In one embodiment, a target protein includes two heterologous domains, and in another embodiment, the target protein includes a heterologous domain and the cell further includes a second protein that includes a heterologous domain. A heterologous domain may include a chromophore or an amino acid to which a fluorescent dye attaches. The fluorescence lifetime of one or more chromophore, one or more fluorescent dye, or the combination thereof, is measured after contacting the cell with a compound A difference between the fluorescence lifetime in the presence of the test compound and the fluorescence lifetime in the absence of the test compound indicates that the test compound alters the FRET of the target protein.

Claims (39)

1. A method for identifying a compound that alters fluorescence resonance energy transfer (FRET) of a protein comprising:

providing a genetically engineered cell comprising a target protein,

wherein the cell is a live cell,

wherein the target protein comprises two heterologous domains, wherein a first heterologous domain comprises a first chromophore, wherein a second heterologous domain comprises a second chromophore, and wherein each heterologous domain comprises a fluorescent protein;

contacting the live cell with a test compound to form a mixture;

measuring the fluorescence lifetime of the first chromophore, the second chromophore, or the combination thereof, of the live cell,

wherein the measuring comprises use of a plate reader and direct waveform recording of fluorescence lifetime decays,

wherein the measuring occurs over a period of time no greater than 0.5 seconds;

calculating a coefficient of variation (CV) for the fluorescence lifetime of the first chromophore, the second chromophore, or the combination thereof, wherein CV is no greater than 0.5%; and

calculating a Z′ parameter, wherein the Z′ parameter is >0.5;

wherein a difference between the fluorescence lifetime in the presence of the test compound and the fluorescence lifetime in the absence of the test compound indicates that the test compound alters the FRET of the target protein.

2. The method of claim 1 wherein the fluorescence lifetime of the first chromophore, the second chromophore, or the combination thereof, is changed in the presence of the test compound.

3. The method of claim 1 adapted for use in a high-throughput format.

4. The method of claim 1 wherein the target protein is stably expressed by the genetically engineered cell.

5. The method of claim 1 wherein the cell is a eukaryotic cell.

6. The method of claim 5 wherein the cell is a vertebrate cell.

7. The method of claim 1 wherein the measuring occurs over a period of time no greater than 0.001 seconds.

8. The method of claim 1 wherein the first chromophore and the second chromophore are selected from a green fluorescent protein, a red fluorescent protein, and a yellow fluorescent protein, or an analogue thereof.

9. The method of claim 1 wherein the cell is in suspension.

10. A method for identifying a compound that alters fluorescence resonance energy transfer (FRET) of a protein comprising:

providing a genetically engineered cell comprising a target protein and a second protein,

wherein the cell is a live cell,

wherein the target protein comprises a first heterologous domain that comprises a first chromophore, and wherein the second protein comprises a second heterologous domain that comprises a second chromophore, and wherein each heterologous domain comprises a fluorescent protein;

contacting the live cell with a test compound to form a mixture; and

measuring the fluorescence lifetime of energy emitted by the first chromophore, the second chromophore, or the combination thereof, of the live cell,

wherein the measuring comprises use of a plate reader and direct waveform recording of fluorescence lifetime decays,

wherein the measuring occurs over a period of time no greater than 0.5 seconds;

calculating a coefficient of variation (CV) for the fluorescence lifetime of the first chromophore, the second chromophore, or the combination thereof, wherein the CV is no greater than 0.5%; and

calculating a Z′ parameter, wherein the Z′ parameter is >0.5;

wherein a difference between the fluorescence lifetime in the presence of the test compound and the fluorescence lifetime in the absence of the test compound indicates that the test compound alters the FRET of the target protein, the second protein, or the combination thereof.

11. The method of claim 10 wherein the target protein and second protein are stably expressed by the genetically engineered cell.

12. The method of claim 10 wherein the fluorescence lifetime of the first chromophore, the second chromophore, or the combination thereof, is changed in the presence of the test compound.

13. The method of claim 10 adapted for use in a high-throughput format.

14. The method of claim 10 wherein the cell is a eukaryotic cell.

15. The method of claim 14 wherein the cell is a vertebrate cell.

16. The method of claim 10 wherein the measuring occurs over a period of time no greater than 0.001 seconds.

17. The method of claim 10 wherein the first chromophore and the second chromophore are selected from a green fluorescent protein, a red fluorescent protein, and a yellow fluorescent protein, or an analogue thereof.

18. The method of claim 10 wherein the cell is in suspension.

19. The method of claim 1 wherein the target protein is transiently expressed by the genetically engineered cell.

Assignments (3)
CONFIRMATORY LICENSE Recorded Mar 17, 2015
From: UNIVERSITY OF MINNESOTA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 035216/0670 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2015
From: ROBIA, SETH LOUIS
To: LOYOLA UNIVERSITY CHICAGO
Reel/Frame 035147/0710 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2015
From: THOMAS, DAVID D.; GRUBER, SIMON J.; CORNEA, RAZVAN L.; GILLISPIE, GREGORY D.; PETERSON, KURT C.
To: REGENTS OF THE UNIVERSITY OF MINNESOTA
Reel/Frame 035147/0753 →
Continuity (2)
Provisional Application 61928565 · Jan 17, 2014
Related Publication 20150204847A1 · Jul 23, 2015